PARENTE, Luca
 Distribuzione geografica
Continente #
NA - Nord America 7.360
AS - Asia 7.310
EU - Europa 2.574
SA - Sud America 234
Continente sconosciuto - Info sul continente non disponibili 221
AF - Africa 42
OC - Oceania 9
Totale 17.750
Nazione #
US - Stati Uniti d'America 7.181
HK - Hong Kong 4.476
SG - Singapore 1.238
IT - Italia 886
CN - Cina 716
UA - Ucraina 559
VN - Vietnam 465
DE - Germania 242
RU - Federazione Russa 221
BR - Brasile 172
IE - Irlanda 165
FI - Finlandia 144
FR - Francia 124
KR - Corea 120
CA - Canada 116
TR - Turchia 84
GB - Regno Unito 70
SE - Svezia 58
IN - India 53
AR - Argentina 26
BD - Bangladesh 26
MX - Messico 25
JP - Giappone 21
IQ - Iraq 19
ES - Italia 16
ID - Indonesia 16
PL - Polonia 16
NL - Olanda 14
EU - Europa 12
CZ - Repubblica Ceca 11
CO - Colombia 10
PK - Pakistan 10
ZA - Sudafrica 9
AT - Austria 7
EC - Ecuador 7
JO - Giordania 7
MY - Malesia 7
CR - Costa Rica 6
MA - Marocco 6
PH - Filippine 6
SA - Arabia Saudita 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
DZ - Algeria 5
JM - Giamaica 5
MD - Moldavia 5
OM - Oman 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
BB - Barbados 4
BO - Bolivia 4
EE - Estonia 4
EG - Egitto 4
ET - Etiopia 4
HU - Ungheria 4
IL - Israele 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
UZ - Uzbekistan 4
BE - Belgio 3
CH - Svizzera 3
HN - Honduras 3
KZ - Kazakistan 3
LT - Lituania 3
MK - Macedonia 3
PR - Porto Rico 3
RO - Romania 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
KE - Kenya 2
MN - Mongolia 2
MZ - Mozambico 2
PE - Perù 2
PY - Paraguay 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BZ - Belize 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
HT - Haiti 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
MC - Monaco 1
ME - Montenegro 1
Totale 17.531
Città #
Hong Kong 4.472
Ann Arbor 1.197
Singapore 714
Jacksonville 687
San Jose 665
Chandler 576
Princeton 445
Ashburn 414
Dallas 355
Dong Ket 295
Milan 295
Wilmington 266
Council Bluffs 228
Houston 187
Dublin 165
Beijing 137
Nanjing 130
Woodbridge 124
Andover 116
The Dalles 113
Lauterbourg 105
Pellezzano 100
Boardman 98
Rome 84
Salerno 83
Izmir 60
Dearborn 58
New York 55
Shenyang 51
Santa Clara 48
Hanoi 47
Ho Chi Minh City 45
Ottawa 45
Fairfield 43
Los Angeles 43
Munich 40
Jiaxing 36
Changsha 34
São Paulo 32
Nanchang 30
Chicago 29
Hebei 28
Frankfurt am Main 26
Moscow 25
Turku 25
Mestre 23
Montreal 23
Düsseldorf 22
Figino 22
Orem 22
Denver 21
Tokyo 21
Atlanta 20
Tianjin 20
Norwalk 19
Washington 19
Brooklyn 18
Jinan 17
Turin 17
Falls Church 16
London 14
Phoenix 14
San Diego 14
Warsaw 14
Columbus 13
Redwood City 12
Chennai 11
Manchester 11
Stockholm 11
Belo Horizonte 10
Bologna 10
Charlotte 10
Guangzhou 10
Memphis 10
Naples 10
San Francisco 10
Dhaka 9
Napoli 9
Poplar 9
Pune 9
Seattle 9
Toronto 9
Amsterdam 8
Boston 8
Cambridge 8
Da Nang 8
Mexico City 8
Mumbai 8
Ankara 7
Brno 7
Campinas 7
Hangzhou 7
Jakarta 7
Madrid 7
Seoul 7
Shanghai 7
Baghdad 6
Bari 6
Des Moines 6
Gragnano 6
Totale 13.517
Nome #
Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of annexin A1. 1.286
Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. 871
Effects of Prisma® Skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts 637
miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing 633
Role of Annexin A1 in mouse myoblast cell differentiation 617
Structure-Based Design, Synthesis and Preliminary Anti-inflammatory Activity of Bolinaquinone Analogues 383
Annexin A1 N-Terminal Derived Peptide Ac2-26 Stimulates Fibroblast Migration in High Glucose Conditions. 338
Annexin A1 Induces Skeletal Muscle Cell Migration Acting through Formyl Peptide Receptors. 303
Advances in the pathophysiology of constitutive and inducible cyclooxygenase: two enzymes in the spotlight. 256
Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells. 252
Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction. 226
Evaluation of in situ injectable hydrogels as controlled release device for ANXA1 derived peptide in wound healing 222
14,15-Secopregnane Derivatives from the Leaves of Solenostemma argel. 216
Annexin A1 Contained in Extracellular Vesicles Promotes the Activation of Keratinocytes by Mesoglycan Effects: An Autocrine Loop Through FPRs 209
Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway 203
Annexin A1: Novel Roles in Skeletal Muscle Biology 201
La macrocortina un inibitore della fosfolipasi indotto dai glucocorticoidi 195
Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid 184
Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation 179
Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System 177
The pharmaceutical device prisma® skin promotes in vitro angiogenesis through endothelial to mesenchymal transition during skin wound healing 172
Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1 163
Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. 159
Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness 159
Annexin 1: more than an antiphospholipase protein 152
R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kB pathway. 151
ROLE OF ANNEXIN A1 IN MIGRATION OF HUMAN PANCREATIC CARCINOMA CELL LINES 151
A new pharmaceutical device containing mesoglycan modulates fibroblasts function in vivo 148
Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation 147
4-Substituted-5-acetyl-2-methyl-6-phenyl-3(2H)pyridazinones as PGE2 and IL-1 release inhibitors from mouse adherent macrophages 146
Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. 142
Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis 136
A novel anti-inflammatory peptide from human lipocortin 5. 131
Gastric antisecretory and anti-ulcer actions of interleukin-1 in rat involve different interleukin-1 receptor types 129
Anaphylactic release of platelet activating factor acether and eicosanoids from lungs of guinea pigs sensitized to ovalbumin aerosol. 127
Anti-inflammatory effect of tuftsin and its retro-inverso analogue in rat adjuvant arthritis 127
LGP1 STIMULATES APOPTOSIS IN U937 ASSOCIATED TO INCREASED ANNEXIN A1 PROTEIN EXPRESSION 125
Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate. 123
Glucocorticoidi 123
Activation of gene expression by interleukin 1. 122
A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. 118
Studies on cell motility in inflammation. I. The chemotactic activity of experimental, immunological and non-immunological, inflammatory exudates. 117
The release of interleukin-1-like activity by macrophages in two models of immunological inflammation in the rat. 116
Mechanisms underlying the protective effects of interleukin-1 in experimental NSAID-gastropathy. 116
Mesoglycan induces the secretion of microvesicles by keratinocytes able to activate human fibroblasts and endothelial cells: A novel mechanism in skin wound healing 113
Induction of gene expression by IL-1 in NIH 3T3 cells. Possible requirement of protein kinase C activity and independence from arachidonic acid metabolism. 111
Rectal temperture and prostaglandin E2 increase in cerebrospinal fluid of conscious rabbits after intracerebroventricular injection of hemoglonin. 110
Consensus italiana sulle raccomandazioni EULAR 2005 per il trattamento dell’artrosi dell’anca. 107
5-Lipoxygenase activation may facilitate an interleukin-1 transduction signal. 107
LGP1, a histone deacetylase inhibitor analogue of FR235222, sensitizes promyelocytic leukemia U937 cells to TRAIL-mediated apoptosis 107
Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells 106
The effect of adrenalectomy on interleukin-1 release in vitro and in vivo. 106
Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. 104
Consensus italiana sulle raccomandazioni dell’EULAR 2003 per il trattamento dell’artrosi del ginocchio. 104
Farmaci antinfiammatori steroidei 104
Evidence for the neuronal origin of immunoreactive interleukin-1beta released by rat hypothalamic explants. 104
Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies 103
Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1. 102
Synthetic alleles at position 121 define a functional domain of human interleukin-1beta 102
Modulation of phospholipase A2 activity in human fibroblasts. 102
Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. 100
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. 100
Corticosteroids microparticles produced by supercritical assisted atomization: process optimization, products characterization and “in vitro” performance 99
Association between glucocorticoids and lipocortin-1 99
I GLICOCORTICOIDI 98
Anti-phospholipase proteins. 98
Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification. 96
Interleukin-1 receptor antagonist displays intrinsic agonist activity on rat gastric fundus motility in vitro 95
Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis. 95
Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin. 95
Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. 95
Are the lipocortins the second messengers of the anti-inflammatory action of glucocorticoids? 95
The annexin 1-/- mouse. 94
Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. 94
IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as Class II acute phase protein. 94
The effect of steroid treatment on lipocortin immunoreactivity of rat brain 94
Peptide 204-212 of lipocortin 5 inhibits the generation of a prostacyclin-like factor from rat aorta preparations in vitro. 93
Proteinase-activated receptor-2 mediates arterial vasodilatation in diabetes 92
Prostaglandin E2 and bacterial lipopolysaccharide stimulate bioactive interleukin-1 release from rat hypothalamic explants. 92
Khellin, but not 8-methoxylpsoralen, inhibits adenylyl cyclase system in HeLa cells 90
Gene structure of the Helicobacter pylori cytotoxin and evidence of its role in gastric disease. 88
The effect of glucocorticoids on lyso-PAF formation in vitro and in vivo. 88
Down-regulation of microglial cyclooxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. 87
Sequential release of TNFalfa and phospholipase A2 in a rat model of LPS-induced pleurisy. 87
Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. 87
Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. 87
Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5. 86
Induction of annexin-1 at transcriptional and post-transcriptional level in rat brain by methylprednisolone and the 21-aminosteroid U74389F. 85
Effect of dexamethasone and phorbol myristate acetate on lipocortin 1, 2 and 5 mRNA and protein synthesis. 85
Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? 84
Evidence that interleukin-1beta and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway. 84
Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. 83
The cyclo-oxygenase pathway in the avascular heart of the frog, Rana esculenta L. 82
Interleukin-1beta- and tumor necrosis factor-induced inhibition of rat gastric fundus motility in vitro. 82
Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. 82
The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs. 80
Dexamethasone-induced translocation of lipocortin (annexin) 1 to the cell membrane of U-937 cells. 80
Increase of extracellular brain calcium is involved in interleukin-1beta-induced pyresis in the rabbit; antagonism by dexamethasone 80
Evidence that the interleukin-1beta-induced prostaglandin E2 release from rat hypothalamus is mediated by type I and type II interleukin-1 receptors 79
Studies on cell motility in inflammation. II. The in vivo effect of anti-inflammatory and anti-rheumatic drugs on chemotaxis in vitro. 79
Totale 16.163
Categoria #
all - tutte 52.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022763 0 0 0 0 16 23 6 30 123 110 103 352
2022/20231.388 127 83 18 158 185 298 0 161 243 5 92 18
2023/2024456 50 71 35 22 50 46 29 26 8 19 20 80
2024/20251.121 63 15 9 48 44 126 210 121 155 35 134 161
2025/20268.413 1.851 2.029 1.181 190 515 260 906 144 242 483 90 522
2026/2027891 121 140 282 342 6 0 0 0 0 0 0 0
Totale 17.750